Uday R Popat

59PUBLICATIONS

189CO-AUTHORS

HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersReproduction

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (59)

Sort by Publication Date:

|Jun 17, 2026

Donor-specific HLA mismatch: haploidentical versus 7/8 mismatched unrelated donor hematopoietic cell transplantation with PTCy.

|May 27, 2026

Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

|May 13, 2026

Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.

|May 06, 2026

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|Apr 26, 2026

Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

|Mar 04, 2026

Evaluating the Impact of Fewer Frontline Intensive Chemotherapy Plus Venetoclax Consolidation Cycles on Outcomes in AML.

Jennifer Marvin-Peek, Hagop Kantarjian, Wei-Ying Jen

Pageof 10

Frequent Collaborators

24 joint publications

Richard E Champlin

15 joint publications

Naval G Daver

15 joint publications

Nicholas Short

14 joint publications

Tapan M Kadia

14 joint publications

Rohtesh S Mehta

14 joint publications

Hagop M Kantarjian

14 joint publications

Courtney DiNardo

13 joint publications

Guillermo Garcia-Manero

12 joint publications

Amanda Olson

12 joint publications

Muzaffar Qazilbash

Frequent Collaborators

24 joint publications

Richard E Champlin

15 joint publications

Naval G Daver

15 joint publications

Nicholas Short

14 joint publications

Tapan M Kadia